Balancing influence between actors in healthcare decision making

BMC Health Services Research

Volumn 11, Issue , 2011, Pages

  Kaplan, Robert M ^a   Babad, Yair M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DECISION MAKING; DEVELOPED COUNTRY; ECONOMICS; HEALTH CARE COST; HEALTH CARE DELIVERY; HUMAN; LIFE EXPECTANCY; ORGANIZATION AND MANAGEMENT; OUTCOME ASSESSMENT; REIMBURSEMENT; STATISTICS; UNITED STATES;

DECISION MAKING; DELIVERY OF HEALTH CARE; DEVELOPED COUNTRIES; HEALTH CARE COSTS; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; LIFE EXPECTANCY; OUTCOME ASSESSMENT (HEALTH CARE); UNITED STATES;

EID: 79955104805     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-11-85     Document Type: Article

References (50)

1. Moving forward on rationing: an economic view. C Donaldson A Bate P Brambleby H Waldner, Bmj 2008 337 1872 10.1136/bmj.a1872 18845596
2. On the front lines of care: primary care doctors' office systems, experiences, and views in seven countries. C Schoen R Osborn PT Huynh M Doty J Peugh K Zapert, Health Aff (Millwood) 2006 25 6 555 571 10.1377/hlthaff.25.w555 (Pubitemid 44871703)
3. Taking the pulse of health care systems: experiences of patients with health problems in six countries. C Schoen R Osborn PT Huynh M Doty K Zapert J Peugh K Davis, Health Aff (Millwood) 2005 Suppl Web Exclusives:W5-509-525
4. National health spending in 2005: the slowdown continues. A Catlin C Cowan S Heffler B Washington, Health Aff (Millwood) 2007 26 1 142 153 10.1377/hlthaff.26.1.142
5. Projecting long term medical spending growth. C Borger TF Rutherford GY Won, J Health Econ 2007
6. US big businesses struggle to cope with health-care costs. P Webster, The Lancet 2006 367 9505 101 102 10.1016/S0140-6736(06)67945-2 (Pubitemid 43077116)
7. It's the premiums, stupid: projections of the uninsured through 2013. T Gilmer R Kronick, Health Aff (Millwood) 2005 Suppl Web Exclusives:W5-143-W145- 151
8. N Daniels, Just Health New York,: Cambridge University Press 2007
9. Associations among hospital capacity, utilization, and mortality of US Medicare beneficiaries, controlling for sociodemographic factors. ES Fisher JE Wennberg TA Stukel JS Skinner SM Sharp JL Freeman AM Gittelsohn, Health Serv Res 2000 34 6 1351 1362 10654835 (Pubitemid 30075414)
10. Shattuck Lecture - the health care industry: where is it taking us? AS Relman, N Engl J Med 1991 325 12 854 859 10.1056/NEJM199109193251205 1875970
11. It's The Premiums, Stupid: Projections Of The Uninsured Through 2013. T Gilmer R Kronick, Health Aff (Millwood) 2005
12. Children welcome, adults need not apply: changes in public program enrollment across states and over time. T Gilmer R Kronick T Rice, Med Care Res Rev 2005 62 1 56 78 10.1177/1077558704271723 15643029 (Pubitemid 41227380)
13. Insuring low-income adults: does public coverage crowd out private? R Kronick T Gilmer, Health Aff (Millwood) 2002 21 1 225 239 10.1377/hlthaff.21.1. 225
14. Getting real about the uninsured problem. R Curtis, Front Health Serv Manage 2005 21 4 39 44 discussion 45-38 16028502
15. The value of medical spending in the United States, 1960-2000. DM Cutler AB Rosen S Vijan, N Engl J Med 2006 355 9 920 927 10.1056/NEJMsa054744 16943404 (Pubitemid 44315984)
16. Measuring quality of life for policy analysis: Past, present, and future. RM Kaplan, Advancing Health Outcomes Research Methods and Clinical Applications McLean VA: Degnon Associates, Lenderking W, Revicki D, 2005 1 35
17. The Ziggy theorem: toward an outcomes-focused health psychology. RM Kaplan, Health Psychology 1994 13 6 451 460 7889899
18. Behavior as the central outcome in health care. RM Kaplan, American Psychologist 1990 45 11 1211 1220 2268090
19. Reimbursement of pharmaceuticals: reference pricing versus health technology assessment. M Drummond B Jonsson F Rutten T Stargardt, Eur J Health Econ 2010 http://www.springerlink.com/content/nl71431ru0308682/fulltext
20. AHRQ series commentary 3: the United States addresses comparative effectiveness but not cost-effectiveness through the effective health-care program. N Freemantle MF Drummond, J Clin Epidemiol 2010 63 5 479 480 10.1016/j.jclinepi.2010.01.008 20346862
21. Cost shifting does not reduce the cost of health care. VR Fuchs, JAMA 2009 302 9 999 1000 10.1001/jama.2009.1278 19724049
22. Risk Adjustment Global Perspectives: United Kingdom, Israel, the Netherlands, Taiwan, Chile, South Africa. Y Babad M Bardsley B Childs C Ghiselli L Lee A McClure M S, Contingencies 2011 2 40 49
23. Rationale and public health implications of changing CHD risk factor definitions. RM Kaplan M Ong, Annu Rev Public Health 2007 28 321 344 10.1146/annurev.publhealth.28.021406.144141 17222077 (Pubitemid 46833346)
24. Creating demand for prescription drugs: a content analysis of television direct-to-consumer advertising. DL Frosch PM Krueger RC Hornik PF Cronholm FK Barg, Ann Fam Med 2007 5 1 6 13 10.1370/afm.611 17261859 (Pubitemid 46193203)
25. Healthcare reform implementation: stakeholders and their roles-the Israeli experience. T Horev YM Babad, Health Policy 2005 71 1 1 21 10.1016/j.healthpol.2004.05.001 15563990 (Pubitemid 39572610)
26. Factors accounting for the rise in health-care spending in the United States: the role of rising disease prevalence and treatment intensity. KE Thorpe, Public Health 2006 120 11 1002 1007 10.1016/j.puhe.2006.09.001 17030050 (Pubitemid 44567193)
27. The rise in spending among Medicare beneficiaries: the role of chronic disease prevalence and changes in treatment intensity. KE Thorpe DH Howard, Health Aff (Millwood) 2006 25 5 378 388 10.1377/hlthaff.25.w378 (Pubitemid 44497611)
28. The boomers are coming: a total cost of care model of the impact of population aging on health care costs in the United States by Major Practice Category. EM Martini N Garrett T Lindquist GJ Isham, Health Serv Res 2007 42 1 Pt 1 201 218 17355589 (Pubitemid 46145533)
29. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. TA Brennan DJ Rothman L Blank D Blumenthal SC Chimonas JJ Cohen J Goldman JP Kassirer H Kimball J Naughton,, et al. Jama 2006 295 4 429 433 10.1001/jama.295.4.429 16434633 (Pubitemid 43144979)
30. Prescription for concern. R Haugh TH Thrall D Scalise, Hosp Health Netw 2002 76 2 44 49 12416463
31. Health care reform and the pharmaceutical industry: crucial decisions are expected. A Liberman J Rubinstein, Health Care Manag (Frederick) 2002 20 3 22 32
32. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. SM Grundy JI Cleeman CN Merz HB Brewer Jr LT Clark DB Hunninghake RC Pasternak SC Smith Jr NJ Stone, Circulation 2004 110 2 227 239 10.1161/01.CIR.0000133317.49796.0E 15249516 (Pubitemid 38924592)
33. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. AV Chobanian GL Bakris HR Black WC Cushman LA Green JL Izzo Jr DW Jones BJ Materson S Oparil JT Wright Jr,, et al. Hypertension 2003 42 6 1206 1252 10.1161/01.HYP.0000107251.49515.c2 14656957 (Pubitemid 37553153)
34. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. AV Chobanian GL Bakris HR Black WC Cushman LA Green JL Izzo Jr DW Jones BJ Materson S Oparil JT Wright Jr,, et al. Jama 2003 289 19 2560 2572 10.1001/jama.289.19.2560 12748199 (Pubitemid 37430158)
35. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. SM Grundy JI Cleeman CN Merz HB Brewer Jr LT Clark DB Hunninghake RC Pasternak SC Smith Jr NJ Stone, J Am Coll Cardiol 2004 44 3 720 732 10.1016/j.jacc.2004.07.001 15358046
36. Follow-up report on the diagnosis of diabetes mellitus. S Genuth KG Alberti P Bennett J Buse R Defronzo R Kahn J Kitzmiller WC Knowler H Lebovitz A Lernmark,, et al. Diabetes Care 2003 26 11 3160 3167 14578255 (Pubitemid 37339514)
37. Reappraisal of the European guidelines on hypertension management: the European Society of Hypertension Task Force document: a short review. R Fagard, Pol Arch Med Wewn 2010 120 1-2 31 35 20150842
38. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. G Mancia S Laurent E Agabiti-Rosei E Ambrosioni M Burnier MJ Caulfield R Cifkova D Clement A Coca A Dominiczak,, et al. J Hypertens 2009 27 11 2121 2158 10.1097/HJH.0b013e328333146d 19838131
39. beta-Adrenergic receptor blockers and heart failure risk after myocardial infarction: a critical review. RH Neumayr PJ Hauptman, Curr Heart Fail Rep 2009 6 4 220 228 10.1007/s11897-009-0031-7 19948090
40. All-cause mortality in randomized trials of cancer screening. WC Black DA Haggstrom HG Welch, J Natl Cancer Inst 2002 94 3 167 173 11830606 (Pubitemid 34162750)
41. Actual causes of death in the United States [see comments]. JM McGinnis WH Foege, Jama 1993 270 18 2207 2212 10.1001/jama.270.18.2207 8411605 (Pubitemid 23323637)
42. Actual causes of death in the United States, 2000. AH Mokdad JS Marks DF Stroup JL Gerberding, JAMA 2004 291 10 1238 1245 10.1001/jama.291.10.1238 15010446 (Pubitemid 38541668)
43. Priorities among recommended clinical preventive services. AB Coffield MV Maciosek JM McGinnis JR Harris MB Caldwell SM Teutsch D Atkins JH Richland A Haddix, Am J Prev Med 2001 21 1 1 9 10.1016/S0749-3797(01)00308-7 11691552 (Pubitemid 32552000)
44. Task Force on Strategic Research Direction: Population/Outcomes/ Epidemiology/Social Science Subgroup key science topics report. L Mosca DK Arnett K Dracup BC Hansen DR Labarthe JS Marks KA Matthews TA Pearson W Weintraub W Wilson, Circulation 2002 106 20 167 172 10.1161/01.CIR.0000040840. 52188.13 12427672
45. MJ Osborne A Rubinstein, A course in game theory Cambridge, Mass.: MIT Press 1994
46. Equilibrium in the Jungle. M Piccione A Rubinstein, The Economic Journal 2007 117 522 883 896 10.1111/j.1468-0297.2007.02072.x (Pubitemid 47040147)
47. Decision making in medicine and health care. RM Kaplan DL Frosch, Annu Rev Clin Psychol 2005 1 525 556 10.1146/annurev.clinpsy.1.102803.144118 17716098 (Pubitemid 43843961)
48. A randomized controlled trial comparing internet and video to facilitate patient education for men considering the prostate specific antigen test. DL Frosch RM Kaplan VJ Felitti, J Gen Intern Med 2003 18 10 781 787 10.1046/j.1525-1497.2003.20911.x 14521639 (Pubitemid 37281771)
49. Shared decision making in clinical medicine: past research and future directions. DL Frosch RM Kaplan, Am J Prev Med 1999 17 4 285 294 10.1016/S0749-3797(99)00097-5 10606197 (Pubitemid 29505475)
50. R Kaplan, Diseases, Diagnoses, and Dollars New York: Cupernicus Press 2009